# Bristol-Myers Squibb revenue entity: /record/bristol-myers-squibb.md predicate: revenue page: /record/bristol-myers-squibb/revenue as_of: 2026-11-09 cite: AsOf. "Bristol-Myers Squibb quarterly revenue: 13,069,000,000 United States dollar", as of 2026-09-30. Claim clm_41E4C7C8DCE2, https://asof.is/claim/clm_41E4C7C8DCE2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm. As of November 9, 2026, the latest revenue figure on the AsOf record for Bristol-Myers Squibb is $13.07 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). Bristol-Myers Squibb's latest full-year revenue is $48.19 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 19 claims on Bristol-Myers Squibb's revenue, 1 open and 18 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest revenue The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_revenue claim, kept apart from the full-year series. Every quarterly revenue figure: /record/bristol-myers-squibb/quarterly_revenue.md - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 13,069,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_41E4C7C8DCE2](/claim/clm_41E4C7C8DCE2.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm ## Latest full-year revenue What the record asserts on 2026-11-09. - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 48,194,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_BB9F55DFC7A5](/claim/clm_BB9F55DFC7A5.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 15,617,000,000 United States dollar | valid 2007-12-31 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_A34D5877A520](/claim/clm_A34D5877A520.md) | [clm_C385A7558EA1](/claim/clm_C385A7558EA1.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 17,715,000,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_5E03D7303B2C](/claim/clm_5E03D7303B2C.md) | [clm_A34D5877A520](/claim/clm_A34D5877A520.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 18,808,000,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_09D474D26D0F](/claim/clm_09D474D26D0F.md) | [clm_5E03D7303B2C](/claim/clm_5E03D7303B2C.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 19,484,000,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_63A21B1FADCA](/claim/clm_63A21B1FADCA.md) | [clm_09D474D26D0F](/claim/clm_09D474D26D0F.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 21,244,000,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_184933260070](/claim/clm_184933260070.md) | [clm_63A21B1FADCA](/claim/clm_63A21B1FADCA.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 17,621,000,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_E61BAA33F6AB](/claim/clm_E61BAA33F6AB.md) | [clm_184933260070](/claim/clm_184933260070.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 16,385,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_E35D5B28759F](/claim/clm_E35D5B28759F.md) | [clm_E61BAA33F6AB](/claim/clm_E61BAA33F6AB.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 15,879,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_B192EABF21B6](/claim/clm_B192EABF21B6.md) | [clm_E35D5B28759F](/claim/clm_E35D5B28759F.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 16,560,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_57A579F455C8](/claim/clm_57A579F455C8.md) | [clm_B192EABF21B6](/claim/clm_B192EABF21B6.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 19,427,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_F2061DAE77B3](/claim/clm_F2061DAE77B3.md) | [clm_57A579F455C8](/claim/clm_57A579F455C8.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 20,776,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_ADD516471339](/claim/clm_ADD516471339.md) | [clm_F2061DAE77B3](/claim/clm_F2061DAE77B3.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 22,561,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_8CDC7F496B1F](/claim/clm_8CDC7F496B1F.md) | [clm_ADD516471339](/claim/clm_ADD516471339.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 26,145,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_1987D0BBF44A](/claim/clm_1987D0BBF44A.md) | [clm_8CDC7F496B1F](/claim/clm_8CDC7F496B1F.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 42,518,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_7C79E3FC9739](/claim/clm_7C79E3FC9739.md) | [clm_1987D0BBF44A](/claim/clm_1987D0BBF44A.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 46,385,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_918266837860](/claim/clm_918266837860.md) | [clm_7C79E3FC9739](/claim/clm_7C79E3FC9739.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 46,159,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_2A5DAEAFCF0E](/claim/clm_2A5DAEAFCF0E.md) | [clm_918266837860](/claim/clm_918266837860.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 45,006,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_78596CC18E60](/claim/clm_78596CC18E60.md) | [clm_2A5DAEAFCF0E](/claim/clm_2A5DAEAFCF0E.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 48,300,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_BB9F55DFC7A5](/claim/clm_BB9F55DFC7A5.md) | [clm_78596CC18E60](/claim/clm_78596CC18E60.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm - [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 48,194,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_BB9F55DFC7A5](/claim/clm_BB9F55DFC7A5.md) sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm ## What replaced what - $15.62 billion (2007-12-31 to 2008-12-31, [clm_C385A7558EA1](/claim/clm_C385A7558EA1.md)) was replaced by $17.72 billion from 2008-12-31 ([clm_A34D5877A520](/claim/clm_A34D5877A520.md)) - $17.72 billion (2008-12-31 to 2009-12-31, [clm_A34D5877A520](/claim/clm_A34D5877A520.md)) was replaced by $18.81 billion from 2009-12-31 ([clm_5E03D7303B2C](/claim/clm_5E03D7303B2C.md)) - $18.81 billion (2009-12-31 to 2010-12-31, [clm_5E03D7303B2C](/claim/clm_5E03D7303B2C.md)) was replaced by $19.48 billion from 2010-12-31 ([clm_09D474D26D0F](/claim/clm_09D474D26D0F.md)) - $19.48 billion (2010-12-31 to 2011-12-31, [clm_09D474D26D0F](/claim/clm_09D474D26D0F.md)) was replaced by $21.24 billion from 2011-12-31 ([clm_63A21B1FADCA](/claim/clm_63A21B1FADCA.md)) - $21.24 billion (2011-12-31 to 2012-12-31, [clm_63A21B1FADCA](/claim/clm_63A21B1FADCA.md)) was replaced by $17.62 billion from 2012-12-31 ([clm_184933260070](/claim/clm_184933260070.md)) - $17.62 billion (2012-12-31 to 2013-12-31, [clm_184933260070](/claim/clm_184933260070.md)) was replaced by $16.39 billion from 2013-12-31 ([clm_E61BAA33F6AB](/claim/clm_E61BAA33F6AB.md)) - $16.39 billion (2013-12-31 to 2014-12-31, [clm_E61BAA33F6AB](/claim/clm_E61BAA33F6AB.md)) was replaced by $15.88 billion from 2014-12-31 ([clm_E35D5B28759F](/claim/clm_E35D5B28759F.md)) - $15.88 billion (2014-12-31 to 2015-12-31, [clm_E35D5B28759F](/claim/clm_E35D5B28759F.md)) was replaced by $16.56 billion from 2015-12-31 ([clm_B192EABF21B6](/claim/clm_B192EABF21B6.md)) - $16.56 billion (2015-12-31 to 2016-12-31, [clm_B192EABF21B6](/claim/clm_B192EABF21B6.md)) was replaced by $19.43 billion from 2016-12-31 ([clm_57A579F455C8](/claim/clm_57A579F455C8.md)) - $19.43 billion (2016-12-31 to 2017-12-31, [clm_57A579F455C8](/claim/clm_57A579F455C8.md)) was replaced by $20.78 billion from 2017-12-31 ([clm_F2061DAE77B3](/claim/clm_F2061DAE77B3.md)) - $20.78 billion (2017-12-31 to 2018-12-31, [clm_F2061DAE77B3](/claim/clm_F2061DAE77B3.md)) was replaced by $22.56 billion from 2018-12-31 ([clm_ADD516471339](/claim/clm_ADD516471339.md)) - $22.56 billion (2018-12-31 to 2019-12-31, [clm_ADD516471339](/claim/clm_ADD516471339.md)) was replaced by $26.15 billion from 2019-12-31 ([clm_8CDC7F496B1F](/claim/clm_8CDC7F496B1F.md)) - $26.15 billion (2019-12-31 to 2020-12-31, [clm_8CDC7F496B1F](/claim/clm_8CDC7F496B1F.md)) was replaced by $42.52 billion from 2020-12-31 ([clm_1987D0BBF44A](/claim/clm_1987D0BBF44A.md)) - $42.52 billion (2020-12-31 to 2021-12-31, [clm_1987D0BBF44A](/claim/clm_1987D0BBF44A.md)) was replaced by $46.39 billion from 2021-12-31 ([clm_7C79E3FC9739](/claim/clm_7C79E3FC9739.md)) - $46.39 billion (2021-12-31 to 2022-12-31, [clm_7C79E3FC9739](/claim/clm_7C79E3FC9739.md)) was replaced by $46.16 billion from 2022-12-31 ([clm_918266837860](/claim/clm_918266837860.md)) - $46.16 billion (2022-12-31 to 2023-12-31, [clm_918266837860](/claim/clm_918266837860.md)) was replaced by $45.01 billion from 2023-12-31 ([clm_2A5DAEAFCF0E](/claim/clm_2A5DAEAFCF0E.md)) - $45.01 billion (2023-12-31 to 2024-12-31, [clm_2A5DAEAFCF0E](/claim/clm_2A5DAEAFCF0E.md)) was replaced by $48.3 billion from 2024-12-31 ([clm_78596CC18E60](/claim/clm_78596CC18E60.md)) - $48.3 billion (2024-12-31 to 2025-12-31, [clm_78596CC18E60](/claim/clm_78596CC18E60.md)) was replaced by $48.19 billion from 2025-12-31 ([clm_BB9F55DFC7A5](/claim/clm_BB9F55DFC7A5.md)) ## Questions this record answers ### What is Bristol-Myers Squibb's current revenue? The latest figure on the record is $13.07 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $48.19 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026. ### What was Bristol-Myers Squibb's revenue for the quarter ended September 30, 2026? $13.07 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did Bristol-Myers Squibb's revenue last change? The latest value on the record is $48.19 billion, dated December 31, 2025; before it the record holds $48.3 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was Bristol-Myers Squibb's revenue before $48.19 billion? $48.3 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/bristol-myers-squibb/revenue (markdown: /record/bristol-myers-squibb/revenue.md) - Entity twin: /record/bristol-myers-squibb.md ยท timeline: /timelines/bristol-myers-squibb.md - Every company's revenue: /facts/revenue.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.